Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease. Schreiber S, Lee SD, van der Woude CJ, Marin-Jimenez I, et al. Inflamm Bowel Dis 2025 Sep 15:izaf163. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Schreiber S, Lee SD, van der Woude CJ, Marin-Jimenez I, et al. Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease. Inflamm Bowel Dis 2025 Sep 15:izaf163. doi: 10.1093.
PMID: 40971924